Perigon Wealth Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$361K Buy
5,626
+501
+10% +$45.7K 0.01% 948
2025
Q4
$667K Buy
5,125
+48
+0.9% +$6.59K 0.01% 671
2025
Q3
$547K Sell
5,077
-108
-2% -$11.8K 0.01% 702
2025
Q2
$479K Buy
+5,185
New +$407K 0.01% 682

Other funds holding WGS

Perigon Wealth Management's WGS Position: Q1 2026 in Review

Perigon Wealth Management increased its GeneDx Holdings (WGS) stake by 9.8% in Q1 2026, buying an estimated $45.7K and bringing the position to 5,626 shares worth $361K. The position accounts for 0.01% of the portfolio, ranked #948.

Perigon Wealth Management first reported a position in WGS in Q2 2025 and has held it in 4 quarters since. The position peaked at $667K in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Perigon Wealth Management held 5,626 shares of GeneDx Holdings worth $361K as of Q1 2026.
  • Perigon Wealth Management bought 501 GeneDx Holdings shares in Q1 2026, an estimated $45.7K.
  • GeneDx Holdings made up 0.01% of Perigon Wealth Management's portfolio in Q1 2026, its #948 holding.
  • Perigon Wealth Management first reported a position in GeneDx Holdings in Q2 2025 and has held it in 4 quarters since.
  • Perigon Wealth Management's GeneDx Holdings position peaked at $667K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.